Bioeconomy Capital

Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.

Completion of Bioeconomy Fund 1

​On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.​

Investments

​Arzeda ​
​Riffyn
​Zymergen
​Synthace
​RoosterBio
​Lumen Bioscience
​Edenworks​
​Bellwether Bio ​

​